Most Viewed Articles from NEJM

To the Editor: In their study, Lopez Bernal et al. (Aug. 12 issue)1 estimate the effectiveness of the BNT162b2 and ChAdOx1 nCoV-19 vaccines against symptomatic disease caused by the B.1.617.2 (delta) variant. The authors encountered a unique